Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 7.72
-0.33 (-4.10%)
May 12, 2026, 3:04 PM CST
SHE:300942 Market Cap
SHE:300942 has a market cap or net worth of 3.13 billion as of May 12, 2026. Its market cap has increased by 0.16% in one year.
Market Cap
3.13B
Enterprise Value
2.99B
Revenue
271.53M
Ranking
n/a
PE Ratio
457.86
Stock Price
7.72
Market Cap Chart
Since February 9, 2021, SHE:300942's market cap has decreased from 14.45B to 3.13B, a decrease of -78.35%. That is a compound annual growth rate of -25.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 3.26B | -14.45% |
| Dec 31, 2025 | 3.81B | 10.95% |
| Dec 31, 2024 | 3.44B | -26.69% |
| Dec 29, 2023 | 4.69B | -31.80% |
| Dec 30, 2022 | 6.87B | -40.61% |
| Dec 31, 2021 | 11.57B | -19.92% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shen Lian Biomedical | 3.62B |
| Guangdong VTR Bio-Tech | 3.54B |
| Zhejiang Shouxiangu Pharmaceutical | 3.45B |
| Novoprotein Scientific | 3.45B |
| Beijing Kawin Technology Share-Holding | 3.36B |
| Yantai Zhenghai Biotechnology | 3.27B |
| Hubei Goto Biopharm | 3.22B |
| Jiangsu Sihuan Bioengineering | 3.19B |